vs
Eventbrite, Inc.（EB）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Eventbrite, Inc.的1.0倍（$75.5M vs $73.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -3.9%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-60.9M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -7.7%）
Eventbrite是源自美国的线下活动服务平台，为用户提供活动浏览、创建与推广服务，支持主办方免费在平台发布不限规模、不限数量的各类活动，是全球范围内活跃度较高的活动交易与推广平台。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
EB vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.0倍
$73.5M
营收增速更快
PBYI
高出31.6%
-3.9%
自由现金流更多
PBYI
多$75.2M
$-60.9M
两年增速更快
PBYI
近两年复合增速
-7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $73.5M | $75.5M |
| 净利润 | $-8.2M | — |
| 毛利率 | 68.1% | 69.3% |
| 营业利润率 | -12.4% | 22.7% |
| 净利率 | -11.1% | — |
| 营收同比 | -3.9% | 27.7% |
| 净利润同比 | 2.5% | — |
| 每股收益（稀释后） | $-0.08 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EBPBYI
| Q4 25 | $73.5M | $75.5M | ||
| Q3 25 | $71.7M | $54.5M | ||
| Q2 25 | $72.8M | $52.4M | ||
| Q1 25 | $73.8M | $46.0M | ||
| Q4 24 | $76.5M | $59.1M | ||
| Q3 24 | $77.8M | $80.5M | ||
| Q2 24 | $84.6M | $47.1M | ||
| Q1 24 | $86.3M | $43.8M |
净利润EBPBYI
| Q4 25 | $-8.2M | — | ||
| Q3 25 | $6.4M | $8.8M | ||
| Q2 25 | $-2.1M | $5.9M | ||
| Q1 25 | $-6.6M | $3.0M | ||
| Q4 24 | $-8.4M | — | ||
| Q3 24 | $-3.8M | $20.3M | ||
| Q2 24 | $1.1M | $-4.5M | ||
| Q1 24 | $-4.5M | $-4.8M |
毛利率EBPBYI
| Q4 25 | 68.1% | 69.3% | ||
| Q3 25 | 67.9% | 77.7% | ||
| Q2 25 | 67.5% | 76.5% | ||
| Q1 25 | 66.9% | 77.1% | ||
| Q4 24 | 68.2% | 76.4% | ||
| Q3 24 | 68.5% | 63.9% | ||
| Q2 24 | 70.9% | 77.4% | ||
| Q1 24 | 71.0% | 75.5% |
营业利润率EBPBYI
| Q4 25 | -12.4% | 22.7% | ||
| Q3 25 | -1.3% | 17.6% | ||
| Q2 25 | -8.7% | 12.7% | ||
| Q1 25 | -13.2% | 8.7% | ||
| Q4 24 | -10.2% | 22.6% | ||
| Q3 24 | -11.5% | 27.4% | ||
| Q2 24 | -7.6% | -4.6% | ||
| Q1 24 | -8.8% | -5.3% |
净利率EBPBYI
| Q4 25 | -11.1% | — | ||
| Q3 25 | 8.9% | 16.2% | ||
| Q2 25 | -2.9% | 11.2% | ||
| Q1 25 | -9.0% | 6.5% | ||
| Q4 24 | -11.0% | — | ||
| Q3 24 | -4.8% | 25.2% | ||
| Q2 24 | 1.3% | -9.6% | ||
| Q1 24 | -5.2% | -11.0% |
每股收益（稀释后）EBPBYI
| Q4 25 | $-0.08 | $0.26 | ||
| Q3 25 | $0.06 | $0.17 | ||
| Q2 25 | $-0.02 | $0.12 | ||
| Q1 25 | $-0.07 | $0.06 | ||
| Q4 24 | $-0.09 | $0.40 | ||
| Q3 24 | $-0.04 | $0.41 | ||
| Q2 24 | $0.01 | $-0.09 | ||
| Q1 24 | $-0.05 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $299.9M | $97.5M |
| 总债务越低越好 | $144.4M | $22.7M |
| 股东权益账面价值 | $179.1M | $130.3M |
| 总资产 | $647.2M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.81× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资EBPBYI
| Q4 25 | $299.9M | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | $441.5M | $101.0M | ||
| Q3 24 | $24.7M | $96.7M | ||
| Q2 24 | $56.7M | $96.8M | ||
| Q1 24 | $113.7M | $107.2M |
总债务EBPBYI
| Q4 25 | $144.4M | $22.7M | ||
| Q3 25 | $174.9M | $34.0M | ||
| Q2 25 | $241.3M | $45.3M | ||
| Q1 25 | $241.0M | $56.7M | ||
| Q4 24 | $240.7M | $68.0M | ||
| Q3 24 | $240.4M | $79.3M | ||
| Q2 24 | $358.7M | $90.7M | ||
| Q1 24 | $358.2M | $102.0M |
股东权益EBPBYI
| Q4 25 | $179.1M | $130.3M | ||
| Q3 25 | $189.1M | $115.3M | ||
| Q2 25 | $177.2M | $104.7M | ||
| Q1 25 | $173.3M | $97.1M | ||
| Q4 24 | $170.2M | $92.1M | ||
| Q3 24 | $179.8M | $71.1M | ||
| Q2 24 | $176.2M | $48.5M | ||
| Q1 24 | $184.1M | $51.0M |
总资产EBPBYI
| Q4 25 | $647.2M | $216.3M | ||
| Q3 25 | $744.6M | $202.9M | ||
| Q2 25 | $784.1M | $194.9M | ||
| Q1 25 | $812.3M | $196.2M | ||
| Q4 24 | $752.3M | $213.3M | ||
| Q3 24 | $817.4M | $220.7M | ||
| Q2 24 | $894.5M | $205.0M | ||
| Q1 24 | $952.2M | $214.1M |
负债/权益比EBPBYI
| Q4 25 | 0.81× | 0.17× | ||
| Q3 25 | 0.92× | 0.30× | ||
| Q2 25 | 1.36× | 0.43× | ||
| Q1 25 | 1.39× | 0.58× | ||
| Q4 24 | 1.41× | 0.74× | ||
| Q3 24 | 1.34× | 1.12× | ||
| Q2 24 | 2.04× | 1.87× | ||
| Q1 24 | 1.95× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-60.8M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-60.9M | $14.4M |
| 自由现金流率自由现金流/营收 | -82.8% | 19.1% |
| 资本支出强度资本支出/营收 | 0.0% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $17.6M | $41.7M |
8季度趋势，按日历期对齐
经营现金流EBPBYI
| Q4 25 | $-60.8M | $14.4M | ||
| Q3 25 | $36.7M | $9.7M | ||
| Q2 25 | $-17.5M | $14.1M | ||
| Q1 25 | $59.4M | $3.6M | ||
| Q4 24 | $-45.3M | $15.6M | ||
| Q3 24 | $44.6M | $11.0M | ||
| Q2 24 | $-32.3M | $1.0M | ||
| Q1 24 | $68.6M | $11.2M |
自由现金流EBPBYI
| Q4 25 | $-60.9M | $14.4M | ||
| Q3 25 | $36.6M | $9.7M | ||
| Q2 25 | $-17.5M | $14.1M | ||
| Q1 25 | $59.4M | $3.6M | ||
| Q4 24 | $-45.3M | $15.6M | ||
| Q3 24 | $44.4M | $11.0M | ||
| Q2 24 | $-32.4M | $1.0M | ||
| Q1 24 | $68.2M | — |
自由现金流率EBPBYI
| Q4 25 | -82.8% | 19.1% | ||
| Q3 25 | 51.1% | 17.7% | ||
| Q2 25 | -24.1% | 26.8% | ||
| Q1 25 | 80.4% | 7.7% | ||
| Q4 24 | -59.2% | 26.4% | ||
| Q3 24 | 57.1% | 13.7% | ||
| Q2 24 | -38.3% | 2.1% | ||
| Q1 24 | 79.1% | — |
资本支出强度EBPBYI
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.0% | 0.0% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.0% | 0.0% | ||
| Q3 24 | 0.2% | 0.0% | ||
| Q2 24 | 0.1% | 0.0% | ||
| Q1 24 | 0.4% | 0.0% |
现金转化率EBPBYI
| Q4 25 | — | — | ||
| Q3 25 | 5.76× | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | -30.37× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EB
| US | $52.0M | 71% |
| Other | $21.6M | 29% |
PBYI
暂无分部数据
